PharmaPrimes is a full-service Contract Research Organization (CRO) providing integrated pharmaceutical R&D, analytical testing, bioanalysis, biosimilar services, clinical research, model-informed drug development, and regulatory support.
PharmaPrimes is a full-service Contract Research Organization (CRO) headquartered in Amman, Jordan, providing integrated scientific services to pharmaceutical and biotechnology companies.
Our capabilities span pharmaceutical R&D, product testing, advanced impurity analysis, bioanalysis, biosimilar characterization, clinical research, bioequivalence, PBPK/PBBM modeling, virtual bioequivalence, and regulatory support.
By integrating specialized scientific departments, advanced analytical infrastructure, quality systems, and clinical capabilities, PharmaPrimes supports pharmaceutical development from early formulation through regulatory submission and lifecycle management.
Integrated scientific services supporting pharmaceutical development from early formulation through regulatory submission and lifecycle management.
Formulation development, process development and optimization, analytical method development and validation, stability studies, regulatory documentation support, and pharmaceutical dossier assessment.
Comprehensive testing of APIs, raw materials, finished products, and stability samples, including impurity analysis, dissolution, elemental impurities, residual solvents, Extractables & Leachables, physical testing, and analytical method development.
Nitrosamine and NDSRI risk assessment, LC-MS/MS and GC-MS/MS method development and validation, confirmatory testing, routine analysis, root-cause investigation, and mitigation support.
Bioanalytical support for small molecules, peptides, therapeutic proteins, monoclonal antibodies, and biologics across preclinical, clinical, bioequivalence, and biosimilar programs.
Analytical characterization, purity and heterogeneity assessment, glycosylation profiling, biological activity, process-related impurity testing, clinical PK, and immunogenicity support.
Hospital-based clinical research through the PharmaPrimes Clinical Research Center located within Jordan Hospital in Amman.
Integrated clinical and bioanalytical support for BE/BA studies and pharmacokinetic evaluation.
Model-Informed Drug Development using PBPK/PBBM modeling and Virtual Bioequivalence simulations.
Scientific and regulatory support including pharmaceutical dossier assessment, CTD documentation support, scientific justification, and regulatory submission support.
R&D → Analytical Testing → Bioanalysis → Regulatory → Clinical
Modern analytical and bioanalytical platforms supporting complex pharmaceutical development programs.
Operations supported by established quality systems and applicable regulatory and accreditation frameworks.
Experienced scientists across pharmaceutical sciences, chemistry, biology, bioanalysis, clinical research, regulatory affairs, and project management.
Supporting pharmaceutical and biotechnology companies across MENA, Europe, and North America.
Multidisciplinary scientific leadership across pharmaceutical sciences, bioanalysis, biologics, quality, and project management.
Founder & CEO | PhD Analytical Chemistry
Pharmaceutical Department Head | MSc Pharmacy
Bioanalysis Department Head | PhD Bioanalytical Chemistry
Biologics & Biosimilars Department Head | BSc Biology
Quality Assurance Manager | BSc Chemistry
Project Management Department Head | MSc Chemistry | PMP
Explore our scientific capabilities, facilities, people, and integrated approach to pharmaceutical development.
PharmaPrimes operates under established quality systems supported by recognized accreditations, certifications, and regulatory authorizations.
ISO/IEC 17025 accreditation applies only to the tests listed in the accredited scope. Scope details are available on request.
Tell us about your development, testing, bioanalytical, or clinical program and our scientific team will prepare a tailored proposal.